fbpx

Contact Lens Market Share Increases Contribute to Cooper Companies Growth in Q2

Cooper Companies reported Q2 (ending April 30, 2015) revenue increases of 5% versus same period last year.  Strong gains (+9%) in CooperVision (CVI), the contact lens business unit of Cooper Companies, offset an 8% decline in CooperSurgical. The company estimates that world-wide CooperVision 2015 calendar quarter 1 contact lenses sales grew 6% versus 1% for the total global market.

Cooper President and CEO, Robert S. Weiss, attributed the sales increase to continued market share gains in contact lenses, and progress with the launch of clariti in US. Single-use spherical lenses showed the greatest growth, up 19% year over year.  In Canada, CooperVision launched clariti brand in June 2015.  Clariti was previously distributed by Centennial Optical.

Gross margins were 61% compared with 65% in last year’s Q2.  The reduction of gross margin was attributed to currency changes, and integration and facility start-up costs.  These were offset in part by favourable product mix.

Featured Posts

SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read More
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read More
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read More
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read More
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more